Title  | Date  | Price  |
|---|
OncoGenex Pharmaceuticals Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Oncolin Therapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Osteologix, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Oncothyreon, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Onyx Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Nymox Pharmaceutical Corporation-Detailed Product Pipeline
| Sep 2009 |
£460 |
Nycomed International Management GmbH-Company Report
| Sep 2009 |
£460 |
Nxstage Medical, Inc.-Deals & Alliances Report
| Sep 2009 |
£370 |
Nutrition 21 Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Ochoa Laboratories Limited-Company Report
| Sep 2009 |
£460 |
Oculus Innovative Sciences Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Optimer Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Opko Health, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
OSI Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Ore Pharmaceuticals Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Osiris Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Oxygen Biotherapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
OXIS International Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Oscient Pharmaceuticals Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |
ONI BioPharma, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Opexa Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Oramed Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Orexigen Therapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Orbus Pharma Inc-Company Report
| Sep 2009 |
£460 |
Northwest Biotherapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Novartis AG-Detailed Product Pipeline
| Sep 2009 |
£460 |
NeurogesX, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
NexMed Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Neuro-Hitech Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Nile Therapeutics, Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Nektar Therapeutics-Detailed Product Pipeline
| Sep 2009 |
£460 |
NeoPharm Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Neurogenesis Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
NovaBay Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Neurocrine Biosciences Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Natrapharm Inc.-Company Report
| Sep 2009 |
£460 |
Nucryst Pharmaceuticals Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |
NanoViricides, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Novus Pharmaceuticals Ltd.-Company Report
| Sep 2009 |
£460 |
Novavax Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
NuRx Pharmaceuticals, Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Novadel Pharma Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Novelos Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Neurobiological Technologies Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Neurologix Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Nutra Pharma Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |
NovImmune SA-Company Report
| Sep 2009 |
£460 |
Neurogen Corporation-Detailed Product Pipeline
| Sep 2009 |
£460 |
NPS Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
OXiGENE INC-Detailed Product Pipeline
| Sep 2009 |
£460 |
Panacos Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Regeneron Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Ardea Biosciences, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Repligen Corporation-Detailed Product Pipeline
| Sep 2009 |
£460 |
RegeneRx Biopharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Rigel Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
QLT Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Questcor Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Pain Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Provectus Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
PolyMedix Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
The Quigley Corporation-Detailed Product Pipeline
| Sep 2009 |
£460 |
Rexahn Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Rockwell Medical Technologies Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Sangamo BioSciences Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Seattle Genetics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Schering-Plough Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |
Shire plc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Sepracor Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Sinofresh Healthcare Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Repros Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
SciClone Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Raptor Pharmaceuticals Corp.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Sucampo Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Palatin Technologies Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Proteo Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Progenics Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Procter & Gamble Company-Detailed Product Pipeline
| Sep 2009 |
£460 |
PanGenex Corporation-Detailed Product Pipeline
| Sep 2009 |
£460 |
PacificHealth Laboratories Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Protalix Biotherapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Pfizer Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
PDL BioPharma Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Pharmos Corporation-Detailed Product Pipeline
| Sep 2009 |
£460 |
Poniard Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Pharmacyclics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Peplin Ltd-Detailed Product Pipeline
| Sep 2009 |
£460 |
PharmAthene, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
POZEN Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Protalex Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Par Pharmaceutical Companies Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Pluristem Therapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Psivida Ltd-Detailed Product Pipeline
| Sep 2009 |
£460 |
Pro-Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Proteonomix, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Polydex Pharmaceuticals Ltd-Detailed Product Pipeline
| Sep 2009 |
£460 |
Penwest Pharmaceuticals Co-Detailed Product Pipeline
| Sep 2009 |
£460 |
Peregrine Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Perrigo Company-Detailed Product Pipeline
| Sep 2009 |
£460 |
Sanguine Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |